Pioneering Medical Innovations

Pioneering Medical Innovations from Concept to Commercialization

About Us

We Measure Success by Insight, Innovation, and Impact

Incept is a unique medical technology accelerator where innovations are nurtured from concept to commercialization—closing critical treatment gaps, improving patients’ lives, and developing inspired industry leaders who will continue to change the world.

We Measure Success by

Insight

0

Years Uncovering
Clinical Needs

26 years of identifying unmet clinical needs, with opportunities to radically elevate the standard of care across multiple specialties.

Innovation

0

Companies
Started

27 successful companies launched and nurtured, with 120 patents developed and 16 successful exits to date.

Impact

+

Patients Treated
Annually

More than 1.3M patients treated annually with devices and technologies developed by Incept companies.

Our Portfolio Companies Do More than Drive Shareholder Value

They Also Save Lives

Structured as an ecosystem of connected innovations, Imperative Care is a purpose-driven company developing next-generation solutions for two of the most overlooked, yet critically devastating conditions in modern medicine: stroke and pulmonary embolism.

Instylla, Inc. is a privately held company focused on delivering next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.

Axtria blends information, analytics, and technology in the cloud to help life sciences organizations gain a competitive edge—improving patient outcomes, and driving business growth.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. 

Acquired by Boston Scientific in 2018, Augmenix, Inc. developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy.

Incept Companies
In the News